Trial · NCT07880535
COMPARİSON OF THE EFFECTS OF ULTRASOUND-GUİDED ERECTOR SPİNAE PLANE BLOCK AND INTRAMUSCULAR NONSTEROİDAL ANTİ-INFLAMMATORY DRUG ADMİNİSTRATİON ON INTRAOPERATİVE ANALGESİA AND PATİENT SATİSFACTİON DURİNG EXTRACORPOREAL SHOCK WAVE LİTHOTRİPSY
NCT07880535, Not applicable, Completed, Sanliurfa Mehmet Akif Inan Education and Research Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. COMPARİSON OF THE EFFECTS OF ULTRASOUND-GUİDED ERECTOR SPİNAE PLANE BLOCK AND INTRAMUSCULAR NONSTEROİDAL ANTİ-INFLAMMATORY DRUG ADMİNİSTRATİON ON INTRAOPERATİVE ANALGESİA AND PATİENT SATİSFACTİON DURİNG EXTRACORPOREAL SHOCK WAVE LİTHOTRİPSY. Trials, record NCT07880535. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07880535
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
COMPARİSON OF THE EFFECTS OF ULTRASOUND-GUİDED ERECTOR SPİNAE PLANE BLOCK AND INTRAMUSCULAR NONSTEROİDAL ANTİ-INFLAMMATORY DRUG ADMİNİSTRATİON ON INTRAOPERATİVE ANALGESİA AND PATİENT SATİSFACTİON DURİNG EXTRACORPOREAL SHOCK WAVE LİTHOTRİPSY
- NCT number
- NCT07880535
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 90 participants, actual
- Lead sponsor
- Sanliurfa Mehmet Akif Inan Education and Research Hospital
- Conditions
- Patient Satisfaction, Extracorporeal Shock Wave Lithotripsy, Erector Spinae Plane Block
- Interventions
- Ultrasound-guided erector spinae plane block, Diclofenac Sodium (DCS)
- First posted
- 2026-10-19
- Last updated
- 2026-10-19
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mean intraoperative pain score (Visual Analog Scale) | During the ESWL procedure (from the first shock wave up to 30 minutes) | Pain intensity during ESWL, self-reported by the patient on a 0-10 Visual Analog Scale (0 = no pain, 10 = worst imaginable pain). Scores are recorded at the first shock wave (0 min) and at 5, 10, 15, 20, 25 and 30 minutes until the end of the session. For each patient, the mean intraoperative VAS score is calculated by averaging all scores recorded during the procedure. |
| Primary | Intraoperative pain scores at each time point (Visual Analog Scale) | At the first shock wave (0 min) and at 5, 10, 15, 20, 25 and 30 minutes of the procedure | Pain intensity on a 0-10 Visual Analog Scale (0 = no pain, 10 = worst imaginable pain), compared between groups at each individual measurement time point during ESWL. |
| Primary | Postprocedural analgesic requirement | At 0, 2, 4, 8, 12 and 24 hours after the procedure | Number (percentage) of patients requiring analgesic medication after ESWL, assessed by an investigator blinded to group allocation. Analgesics are given on patient request. |
| Secondary | Mean arterial pressure | Baseline (before the procedure) and at 5, 10, 15, 20, 25 and 30 minutes of the procedure | Non-invasive mean arterial pressure (mmHg) monitored throughout the ESWL procedure. |
| Secondary | Heart rate | Baseline (before the procedure) and at 5, 10, 15, 20, 25 and 30 minutes of the procedure | Heart rate (beats/min) monitored by ECG throughout the ESWL procedure. |
| Secondary | Patient satisfaction | Within 24 hours after the procedure | Patient satisfaction with analgesia during ESWL, rated on a five-point Likert scale (1 = very dissatisfied, 5 = very satisfied) and assessed by an investigator blinded to group allocation. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07880535
GET https://conductscience.org/api/trials/v1/NCT07880535/registered